Compound ID | 1373
Class: Cyclin dependant kinase-2 inhibitor/ ATR inhibitor
Details of activity: | Has been shown to be an effective inhibitor of Mycobacterium tuberculosis |
Institute where first reported: | Cayman Chemical |
Year first mentioned: | 2011 |
Highest developmental phase: | Preclinical |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/398148 |
Citations: |
|